Xeris Pharmaceuticals Inc - Price Earnings Ratio

Xeris Pharmaceuticals Inc's Fiscal Year is From January To December.

The item "Price-Earnings-Ratio" stands at -86.62 as of 09/30/2025, the lowest value at least since 03/31/2024, the period currently displayed.

As of the end of Xeris Pharmaceuticals Inc's third quarter, the item "Price Earnings Ratio" stands at -86.62. This represents a decrease of -246.91 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -78.89 compared to the value the year prior.
The Serie's long term average value is -21.24. It's latest available value, on 09/30/2025, is -65.38 lower, compared to it's long term average value.
The Serie's change from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0 .
The Serie's change from it's maximum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is -80.64 .